NumerixS Investment Technologies’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-6,400
| Closed | -$26K | – | 1426 |
|
|
2018
Q4 | $26K | Sell |
6,400
-4,800
| -43% | -$19.5K | 0.01% | 889 |
|
|
2018
Q3 | $69K | Sell |
11,200
-4,600
| -29% | -$28.3K | 0.01% | 904 |
|
|
2018
Q2 | $128K | Buy |
15,800
+9,800
| +163% | +$79.4K | 0.03% | 671 |
|
|
2018
Q1 | $44K | Buy |
+6,000
| New | +$44K | 0.01% | 834 |
|
|
2017
Q3 | – | Sell |
-8,700
| Closed | -$59K | – | 1430 |
|
|
2017
Q2 | $59K | Sell |
8,700
-21,100
| -71% | -$143K | 0.01% | 936 |
|
|
2017
Q1 | $281K | Sell |
29,800
-5,300
| -15% | -$50K | 0.03% | 608 |
|
|
2016
Q4 | $303K | Buy |
+35,100
| New | +$303K | 0.04% | 547 |
|
|
2016
Q2 | – | Sell |
-30,136
| Closed | -$131K | – | 1291 |
|
|
2016
Q1 | $131K | Sell |
30,136
-900
| -3% | -$3.91K | 0.02% | 791 |
|
|
2015
Q4 | $190K | Buy |
31,036
+17,936
| +137% | +$110K | 0.02% | 704 |
|
|
2015
Q3 | $75K | Buy |
+13,100
| New | +$75K | 0.01% | 620 |
|